Valeria Barcelli - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Valeria Barcelli

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Npj Drug Discovery|July 1, 2026

AI-guided competitive docking for virtual screening and compound efficacy predictionManon Mirgaux, Valeria Barcelli, Adeline C Y Chua, et al.

Microbiology Spectrum|May 18, 2026

<i>In vitro</i> antimicrobial resistance properties of rifapentine and rifampicin are indistinguishableValeria Barcelli, Bora Shin, Barry Boon Liang Choo, et al.

NPJ Vaccines|August 25, 2023

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosisShivankari Krishnananthasivam, Hao Li, Rania Bouzeyen, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Npj Drug Discovery|July 1, 2026

AI-guided competitive docking for virtual screening and compound efficacy predictionManon Mirgaux, Valeria Barcelli, Adeline C Y Chua, et al.

Microbiology Spectrum|May 18, 2026

<i>In vitro</i> antimicrobial resistance properties of rifapentine and rifampicin are indistinguishableValeria Barcelli, Bora Shin, Barry Boon Liang Choo, et al.

NPJ Vaccines|August 25, 2023

An anti-LpqH human monoclonal antibody from an asymptomatic individual mediates protection against Mycobacterium tuberculosisShivankari Krishnananthasivam, Hao Li, Rania Bouzeyen, et al.

Pageof 1